Mitchell B. Max

17.4k total citations · 5 hit papers
100 papers, 10.8k citations indexed

About

Mitchell B. Max is a scholar working on Physiology, Pharmacology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Mitchell B. Max has authored 100 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Physiology, 31 papers in Pharmacology and 24 papers in Anesthesiology and Pain Medicine. Recurrent topics in Mitchell B. Max's work include Pain Mechanisms and Treatments (58 papers), Botulinum Toxin and Related Neurological Disorders (19 papers) and Pain Management and Opioid Use (18 papers). Mitchell B. Max is often cited by papers focused on Pain Mechanisms and Treatments (58 papers), Botulinum Toxin and Related Neurological Disorders (19 papers) and Pain Management and Opioid Use (18 papers). Mitchell B. Max collaborates with scholars based in United States, Australia and Canada. Mitchell B. Max's co-authors include Richard H. Gracely, Ronald Dubner, Bruce M Smoller, Susan Schafer, Inna Belfer, David Goldman, Joanne Muir, Mary Culnane, William Maixner and Sue Lynch and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Neuroscience.

In The Last Decade

Mitchell B. Max

94 papers receiving 10.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetic basis for individual variations in pain perception and the development of a chronic pain condition

2004 947 citations Luda Diatchenko, Inna Belfer et al. Human Molecular Genetics profile →
Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic Neuropathy

1992 794 citations Mitchell B. Max, Susan E. Shoaf et al. New England Journal of Medicine profile →
Quality Improvement Guidelines for the Treatment of Acute Pain and Cancer Pain

1995 669 citations Mitchell B. Max profile →
Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2)

2009 528 citations Robert H. Dworkin, Dennis C. Turk et al. Pain profile →
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1987 502 citations Mitchell B. Max, Mary Culnane et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell B. Max United States	52	5.6k	3.3k	2.7k	1.9k	1.7k	100	10.8k
Michael C. Rowbotham United States	52	8.3k 1.5×	4.1k 1.2×	2.6k 0.9×	3.3k 1.7×	1.9k 1.1×	130	13.5k
Ian Gilron Canada	48	5.8k 1.0×	3.0k 0.9×	2.7k 1.0×	2.1k 1.1×	1.4k 0.8×	202	10.8k
Bradley S. Galer United States	49	4.2k 0.7×	2.9k 0.9×	2.8k 1.0×	1.6k 0.8×	795 0.5×	125	8.3k
Miroslav Bačkonja United States	36	6.0k 1.1×	2.9k 0.9×	2.4k 0.9×	2.6k 1.4×	1.0k 0.6×	86	8.9k
Thomas R. Tölle Germany	58	6.5k 1.2×	4.3k 1.3×	1.7k 0.6×	2.3k 1.2×	2.6k 1.5×	171	12.0k
Per Hansson Sweden	53	11.0k 2.0×	5.4k 1.6×	2.8k 1.0×	4.3k 2.2×	2.5k 1.5×	167	16.7k
Maija Haanpää Finland	34	6.0k 1.1×	2.4k 0.7×	1.9k 0.7×	2.7k 1.4×	983 0.6×	84	9.1k
Turo Nurmikko United Kingdom	47	8.2k 1.5×	4.1k 1.2×	2.4k 0.9×	5.5k 2.8×	1.7k 1.0×	107	14.6k
Elon Eisenberg Israel	45	3.5k 0.6×	3.3k 1.0×	3.2k 1.2×	761 0.4×	1.0k 0.6×	145	7.7k
Philip J. Siddall Australia	38	4.3k 0.8×	2.7k 0.8×	1.3k 0.5×	1.5k 0.8×	917 0.5×	84	8.1k

Countries citing papers authored by Mitchell B. Max

Since Specialization

Citations

This map shows the geographic impact of Mitchell B. Max's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell B. Max with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell B. Max more than expected).

Fields of papers citing papers by Mitchell B. Max

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell B. Max. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell B. Max. The network helps show where Mitchell B. Max may publish in the future.

Co-authorship network of co-authors of Mitchell B. Max

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell B. Max. A scholar is included among the top collaborators of Mitchell B. Max based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell B. Max. Mitchell B. Max is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dworkin, Robert H., Dennis C. Turk, Dennis A. Revicki, et al.. (2009). Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain. 144(1). 35–42. 528 indexed citations breakdown →

Dworkin, Robert H., Richard L. Barbano, Stephen K. Tyring, et al.. (2009). A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain. 142(3). 209–217. 54 indexed citations

Wu, Christopher L., Shefali Agarwal, Prabhav K. Tella, et al.. (2008). Morphine versus Mexiletine for Treatment of Postamputation Pain. Anesthesiology. 109(2). 289–296. 81 indexed citations

Shabalina, Svetlana A., Dmitri V. Zaykin, Pavel Gris, et al.. (2008). Expansion of the human μ-opioid receptor gene architecture: novel functional variants. Human Molecular Genetics. 18(6). 1037–1051. 126 indexed citations

Turk, Dennis C., Robert H. Dworkin, Dennis A. Revicki, et al.. (2007). Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain. 137(2). 276–285. 374 indexed citations

Diatchenko, Luda, Amy D. Anderson, Gary D. Slade, et al.. (2006). Three major haplotypes of the β₂ adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 141B(5). 449–462. 152 indexed citations

Edwards, Robert R., Brendan Klick, Luis F. Buenaver, et al.. (2006). Symptoms of distress as prospective predictors of pain-related sciatica treatment outcomes. Pain. 130(1). 47–55. 60 indexed citations

Edwards, Robert R., Jennifer A. Haythornthwaite, Prabhav K. Tella, Mitchell B. Max, & Srinivasa N. Raja. (2006). Basal Heat Pain Thresholds Predict Opioid Analgesia in Patients with Postherpetic Neuralgia. Anesthesiology. 104(6). 1243–1248. 105 indexed citations

Khoromi, Suzan, Ranganath Muniyappa, Lisa M. Nackers, et al.. (2006). Effects of Chronic Osteoarthritis Pain on Neuroendocrine Function in Men. The Journal of Clinical Endocrinology & Metabolism. 91(11). 4313–4318. 21 indexed citations

10.

Khoromi, Suzan, Lihong Cui, Lisa M. Nackers, & Mitchell B. Max. (2006). Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain. 130(1). 66–75. 164 indexed citations

11.

Belfer, Inna, Beáta Búzás, Heather S. Hipp, et al.. (2004). Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans. European Journal of Human Genetics. 13(3). 341–351. 33 indexed citations

12.

Jamison, Robert N., Jeff Schein, S. Vallow, et al.. (2003). Abtracts Diagnosis, assessment, and reviews. Journal of Pain. 4(2). 1–104. 1 indexed citations

13.

Seltzer, Ze’ev, Tianxia Wu, Mitchell B. Max, & Scott R. Diehl. (2001). Mapping a gene for neuropathic pain-related behavior following peripheral neurectomy in the mouse. Pain. 93(2). 101–106. 41 indexed citations

14.

Arends, Rosalin, et al.. (1997). Pharmacokinetic-pharmacodynamic correlation of ibuprofen analgesia Comparison between ibuprofen arginate and motrin IB. Clinical Pharmacology & Therapeutics. 61(2). 199. 2 indexed citations

15.

Dionne, Raymond A., et al.. (1996). Evaluation of a Neurokinin1 antagonist, CP-99,994, in comparison to ibuprofen and placebo in the oral surgery model.. Clinical Pharmacology & Therapeutics. 59(2). 216–216. 9 indexed citations

16.

Max, Mitchell B., et al.. (1992). Effects of a single oral dose of desipramine on postoperative morphine analgesia. Journal of Pain and Symptom Management. 7(8). 454–462. 15 indexed citations

17.

Max, Mitchell B., et al.. (1991). Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 45(1). 3–9. 237 indexed citations

18.

Max, Mitchell B., Susan Schafer, Mary Culnane, Ronald Dubner, & Richard H. Gracely. (1988). Association of pain relief with drug side effects in postherpetic neuralgia: A single-dose study of clonidine, codeine, ibuprofen, and placebo. Clinical Pharmacology & Therapeutics. 43(4). 363–371. 198 indexed citations

19.

Max, Mitchell B., Charles E. Inturrisi, Robert F. Kaiko, et al.. (1985). Epidural and intrathecal opiates: Cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clinical Pharmacology & Therapeutics. 38(6). 631–641. 74 indexed citations

20.

Inturrisi, Charles E., et al.. (1984). The Pharmacokinetics of Heroin in Patients with Chronic Pain. New England Journal of Medicine. 310(19). 1213–1217. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact